Inequities in insurance status among Americans adversely affect their ability to obtain the entire range of cancer care. Those who are members of ethnic minorities and the working poor are especially apt to have poorer access to care and reduced quality of cancer care services as a result.L. A...
Calman–Hine was the first comprehensive cancer report to be produced in the UK, and set out principles for cancer care and the clinical organisation for service delivery. It advocated a change from a generalist model (eg, care given by general surgeons and physicians) that was supported by sp...
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy In a systematic review and meta-analysis of nonrelapse mortality (NRM) following CAR T cell treatment in 7,604 patients with lymphoma and myeloma, almost half of cases were atrributable to infections and ...
2Cancer Research UK. Longer, better lives: A manifesto for cancer research and care. Available athttps://www.cancerresearchuk.org/sites/default/files/cruk_manifesto.pdf. Last accessed March 2024. 3Hanna, T.P. et al. (2020)‘Mortality due to cancer treatment delay: Sys...
A review and characterization of the various perceptions of quality cancer careA review and characterization of the various perceptions of quality cancer caredoi:10.1002/cncr.25644quality of healthcarequality indicatorsquality assuranceneoplasms/drug therapycancer...
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review. Cells 2023, 12, 2159. https://doi.org/10.3390/cells12172159 AMA Style Kaczmarek M, Poznańska J, Fechner F, Michalska N, Paszkowska S, Napierała A, Mackiewicz A. Cancer Vaccine Therapeutics: Limitations and ...
To critically review new information so that breast cancer specialists can integrate it into daily practice To promote academic skills in young specialists Who can attend? Breast Cancer Surgeons,Breast Cancer Pathologists, Radiation Oncologist, Radiation Therapist, Breast Care Nurse, Reconstructive (plastic...
National Institute for Health and Care Excellence decisions commonly relied on the same set of surrogate measures used by the FDA for accelerated approval. Policy makers in England who are currently seeking to expedite NICE appraisals may wish to consider that decreasing review times will further ...
UK, owing to mandatory reporting of cancer outcomes within the NHS [14]. However, due to data being curated from multiple sources, there is a time lag to completeness, with data from cancer registries usually complete within 2 years of diagnosis. Primary care records include data on rapid ...
of institutional healthcare in the United States. In that capacity, Ken’s primary focus was as trial counsel in medical malpractice cases defending all manner of care providers in Federal and State courts as well as before various licensing and review boards on behalf of individual practitioners....